(MENAFN- GlobeNewsWire - Nasdaq) Selbyville, Delaware, Aug. 07, 2023 (GLOBE NEWSWIRE) --
Cloning And Mutagenesis market size is expected to be worth USD 14.6 billion by 2032. The industry expansion is backed by a wide range of applications and techniques. There is a surge in demand for genetically modified organisms (GMOs) in various fields, including agriculture, pharmaceuticals, and research. Cloning and mutagenesis techniques offer researchers the ability to manipulate and engineer genes to create desired traits or characteristics in organisms.
Request for a sample of this research report @
Moreover, the supportive government policies and funding initiatives that aim to accelerate scientific research and promote the commercialization of biotechnological products will shape the industry outlook in coming years.
Advanced technology incorporation to increase adoption of mutagenesis kits
The cloning and mutagenesis market is divided into mutagenesis kits, cloning kits, and others. The mutagenesis segment is expected to grow through 2032 attributed to the availability of user-friendly and cost-effective kits. This has greatly simplified the process of generating genetic mutations, making it more accessible to a wider range of researchers. Mutagenesis kits provide researchers with the necessary tools and reagents to induce targeted genetic mutations in organisms, enabling them to study gene function, create disease models, and develop novel biotechnological products. The incorporation of advanced technologies, such as CRISPR-Cas9 or other site-directed techniques, the allow precise & efficient editing of DNA sequences.
Benefits of site-directed mutagenesis to promote market expansion
The cloning and mutagenesis market is bifurcated into seamless cloning, TOPO PCR cloning, site-directed mutagenesis, blunt-end cloning, and others. The site-directed mutagenesis segment is anticipated to grow at rapid pace from 2023 to 2032. The technique allows researchers to precisely modify genes, create point mutations, insert or delete specific DNA fragments, and study the functional implications of these changes. Site-directed mutagenesis technique has revolutionized the field of molecular biology by enabling researchers to investigate the role of specific amino acids, study protein structure-function relationships, and explore gene regulation mechanisms. The technology applications in various areas, including drug development, protein engineering, and understanding genetic diseases is adding to segment share.
Growing research efforts in APAC region to spike product demand
Asia Pacific cloning and mutagenesis market size is predicted to witness significant progression through 2032. The region's large population and rising healthcare expenditure, coupled with a growing focus on personalized medicine are encouraging the numerous medical researchers. The supportive government initiatives, collaborations between academic institutions and industry players, and the availability of skilled researchers are creating a conducive environment for R&D in the field of cloning & mutation. Rising prevalence of genetic disorders, along with increasing investments in biotech as well as biopharma are supporting the development of APAC industry.
Request for Report Customization @
Global cloning & mutagenesis market players
The key players profiled in the cloning and mutagenesis market report are Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., TransGen Biotech Co., Ltd., Merck KGaA, Danaher, Jena Bioscience GmbH, Takara Bio Inc., New England Biolabs, Promega Corporation, Genomax Technologies Pte Ltd., Assay Genie, Genes2Me, and GenScript, among others.
Partial Table of Contents (ToC) of the report:
Chapter 3 Cloning and Mutagenesis Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for precision medicine
3.2.1.2 Rising demand for genetically modified products
3.2.1.3 Advancements in genetic engineering techniques
3.2.2 Industry pitfalls & challenges
3.2.2.1 High maintanance cost of cloning and mutagenesis tools & instruments
3.2.2.2 Limited availability of qualified researchers
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By technology
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Technology lndscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard, 2022
Browse Our Reports Store - GMIPulse @
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Tags dna cloning cloning vectors plasmid cloning restriction enzymes random mutagenesis chemical mutagenesis point mutations Related Links biosimilars market laser-induced breakdown spectroscopy (libs) market lab automation market genetic testing market gene vector market gene synthesis market genomics services market gene therapy market artificial intelligence in genomics market spatial genomics and transcriptomics market